EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
You are here
Document 62021TJ0074
/
DECISION
- Title
- Judgment of the General Court (Third Chamber, Extended Composition) of 18 October 2023. Teva Pharmaceutical Industries Ltd and Cephalon Inc. v European Commission. Competition – Agreements, decisions and concerted practices – Modafinil market – Decision finding an infringement of Article 101 TFEU – Patent dispute settlement agreement – Restriction of competition by object – Characterisation – Restriction of competition by effect – Conditions for exemption under Article 101(3) TFEU – Fines. Case T-74/21.
- ECLI identifier
- ECLI:EU:T:2023:651
- Applicant
- Individual
- Defendant
- European Commission, EU institutions and bodies
- Judge-Rapporteur
- Schalin
- Type of procedure
- Action for annulment - unfounded
- Complementary documents:
18/10/2023